<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101120682</journal-id>
<journal-id journal-id-type="pubmed-jr-id">22474</journal-id>
<journal-id journal-id-type="nlm-ta">Best Pract Res Clin Endocrinol Metab</journal-id>
<journal-id journal-id-type="iso-abbrev">Best Pract. Res. Clin. Endocrinol. Metab.</journal-id>
<journal-title-group>
<journal-title>Best practice &amp; research. Clinical endocrinology &amp; metabolism</journal-title>
</journal-title-group>
<issn pub-type="ppub">1521-690X</issn>
<issn pub-type="epub">1878-1594</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29779582</article-id>
<article-id pub-id-type="pmc">6029710</article-id>
<article-id pub-id-type="doi">10.1016/j.beem.2018.03.011</article-id>
<article-id pub-id-type="manuscript">NIHMS960818</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Animal Models of Endocrine Disruption</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Patisaul</surname>
<given-names>Heather B</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<!--<email>hbpatisa@ncsu.edu</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fenton</surname>
<given-names>Suzanne E.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
<!--<email>suzanne.fenton@nih.gov</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aylor</surname>
<given-names>David</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A3">3</xref>
<!--<email>dlaylor@ncsu.edu</email>-->
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Center for Human Health and the Environment, W.M. Keck Center for Behavioral Biology, Department of Biological Sciences, North Carolina State University, Raleigh, NC, 27695</aff>
<aff id="A2">
<label>2</label>Division of the National Toxicology Program (DNTP), NTP Laboratory, National Institute of Environmental Health Sciences (NIEHS), National Institute of Health (NIH), Research Triangle Park, NC 27709, USA</aff>
<aff id="A3">
<label>3</label>Center for Human Health and the Environment, Bioinformatics Research Center, W.M. Keck Center for Behavioral Biology, Department of Biological Sciences, North Carolina State University, Raleigh, NC, 27695</aff>
<author-notes>
<corresp id="FN1">Contact Author: Heather B. Patisaul, Professor, Biological Sciences, NC State University, 127 David Clark Labs, Raleigh, NC 27695, <email>hbpatisa@ncsu.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p><bold>Conflict of Interest Statement:</bold> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>18</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>06</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>32</volume>
<issue>3</issue>
<fpage>283</fpage>
<lpage>297</lpage>
<!--elocation-id from pubmed: 10.1016/j.beem.2018.03.011-->
<abstract>
<p id="P2">Endocrine disrupting chemicals (EDCs) are compounds that alter the structure and function of the endocrine system and may be contributing to disorders of the reproductive, metabolic, neuroendocrine and other complex systems. Typically, these outcomes cannot be modeled in cell-based or other simple systems necessitating the use of animal testing. Appropriate animal model selection is required to effectively recapitulate the human experience, including relevant dosing and windows of exposure, and ensure translational utility and reproducibility. While classical toxicology heavily relies on inbred rats and mice, and focuses on apical endpoints such as tumor formation or birth defects, EDC researchers have used a greater diversity of species to effectively model more subtle but significant outcomes such as changes in pubertal timing, mammary gland development, and social behaviors. Advances in genomics, neuroimaging and other tools are making a wider range of animal models more widely available to EDC researchers.</p>
</abstract>
<kwd-group>
<kwd>zebrafish</kwd>
<kwd>vole</kwd>
<kwd>peromyscus</kwd>
<kwd>toxicology</kwd>
<kwd>neurosciences</kwd>
<kwd>collaborative cross</kwd>
<kwd>PFOA</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>